Orangebiomed ^Company

Orangebiomed is developing "OBM rapid A1c", a point-of-care in vitro diagnosis medical device(IVD) for HbA1c monitoring. Deploying cutting-edge technologies to diagnose diabetes and providing monitoring solution within your home environment, Orangebiomed is changing the way you receive healthcare. OBM rapid A1c provides lab-accurate HbA1c results within 15 minutes at the point of care. With OBM rapid A1c, patients can easily monitor their A1c level within their home environment on a regular basis, saving time traveling back and forth from doctor's office.